In the original version of this article (1), the “Crizotinib” label in Fig. 4F is incorrect; the label should be “Selumetinib”. The error has been corrected in the latest online HTML and PDF versions of the article. The publisher regrets the error.

1.
Suzuki
S
,
Yonesaka
K
,
Teramura
T
,
Takehara
T
,
Kato
R
,
Sakai
H
, et al
KRAS inhibitor resistance in MET-amplified KRASG12C non–small cell lung cancer induced by RAS- and non–RAS-mediated cell signaling mechanisms
.
Clin Cancer Res
2021
;
27
:
5697
707
.